María Asunción Esteve-Pastor

20PUBLICATIONS
13CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Respiratory diseasesHaematologyMolecular targetsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 31, 2025
Evaluation of the Presence of Native Valvular Disease in Patients With Atrial Fibrillation Using the EHRA (Evaluated Heartvalves, Rheumatic, or Artificial) Classification.

Antonio Escolar Conesa, María Asunción Esteve-Pastor, Vanessa Roldán

|Feb 22, 2025
The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study.

Eva Soler-Espejo, Francisco Marín, Raquel López-Gálvez

|Nov 01, 2022
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.

María A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán

|Aug 04, 2022
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry.

María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Martín Ruiz-Ortiz

|Feb 02, 2021
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes.

María Asunción Esteve-Pastor, Ernesto Martín, Oriol Alegre

|Dec 09, 2020
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.

Marco Proietti, José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor

Pageof 4

Frequent Collaborators

14 joint publications

José Miguel Rivera-Caravaca

6 joint publications

Gregory Y H Lip

5 joint publications

Francisco Marin

3 joint publications

Vanessa Roldán